Sponsor Pipeline

Castle Creek Biosciences, LLC. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
0
Recruiting
2
Phase 3
Active Trials by Phase
Phase 3
2
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT06892639 Evaluation of D-Fi for the Treatment of Wounds Due to DEB Dystrophic Epidermolysis Bullosa Active, Not Recruiting
NCT04213261 A Study of FCX-007 for Recessive Dystrophic Epidermolysis Bullosa Recessive Dystrophic Epidermolysis Bullosa Active, Not Recruiting
Get alerts when Castle Creek Biosciences, LLC.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free